SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Stock Price Down 1.2% – Time to Sell?

SWEDISH ORPHAN/S (OTCMKTS:SWTUY) shares were down 1.2% during trading on Tuesday. The stock traded as low as $24.38 and last traded at $24.38. 200 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.

SWEDISH ORPHAN/S Trading Down 1.2%

The business has a 50-day moving average of $24.38 and a 200 day moving average of $24.38. The firm has a market capitalization of $6.64 billion, a P/E ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81.

About SWEDISH ORPHAN/S

Swedish Orphan Biovitrum AB, commonly known as Sobi, is a Sweden-based biopharmaceutical company focused on developing and providing treatments for rare diseases. The company’s activities primarily cover hematology, immunology, and other conditions in which patients have limited treatment options.

Sobi’s portfolio includes therapies for bleeding disorders, immune-mediated diseases, and rare inflammatory conditions. Its products and services span the development, manufacturing, commercialization, and distribution of medicines, with the company also working with external partners to bring specialized treatments to patients.

Headquartered in Stockholm, Sobi serves patients and healthcare providers internationally through operations and commercial partnerships across Europe, North America, and other markets.